...
首页> 外文期刊>Pharmacoepidemiology and drug safety >Response to the letter to the editor entitled 'Diclofenac: Increase of myocardial infarctions at low doses?' (PDS 13-0441) authored by K Brune
【24h】

Response to the letter to the editor entitled 'Diclofenac: Increase of myocardial infarctions at low doses?' (PDS 13-0441) authored by K Brune

机译:对写给《双氯芬酸:低剂量增加心肌梗塞?》的编辑的答复(PDS 13-0441)由K Brune撰写

获取原文
获取原文并翻译 | 示例

摘要

We thank Prof. Dr. Brune for his interest in our recently published manuscript entitled "Myocardial infarction and individual nonsteroidal anti-inflammatory drugs meta-analysis of observational stiidies."1 We would like to point to information in the paper that we believe addresses his concerns on the reported dose effects for diclofenac. In our publication, we stated in the methods section "A dose-response analysis used the reported low-medium and high-dose estimates from each stiidy." In the results section, when describing the dose effects, we reported that "11 studies were describing the effect of individual NSAID dose on the risk of AMI [acute myocardial infarction]. Most studies used similar cut-off values to define low-medium and high daily doses, except for naproxen, for which definitions varied widely across stiidies.
机译:感谢Brune博士对我们最近发表的题为“心肌梗塞和观察性研究的个体非甾体类抗炎药的荟萃分析”的论文感兴趣。[1]我们想指出论文中我们认为可以解决他的问题的信息。关注双氯芬酸的剂量影响。在我们的出版物中,我们在方法部分中指出:“剂量反应分析使用了每种药的报道的中低剂量估计值。”在结果部分中,当描述剂量影响时,我们报告说:“有11项研究描述了单独NSAID剂量对AMI(急性心肌梗塞)风险的影响。大多数研究使用相似的临界值来定义中低和除萘普生外,每天的剂量都很高,不同药物之间的定义差异很大。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号